ArticleFrontiers in public health2026
When institutions, technologies, and platforms co-evolve: a triadic co-evolutionary framework for public health governance in regulated digital service industries.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
How do institutional constraints, technological embeddedness, and platform governance co-evolve to reconfigure the public health governance of regulated digital service industries? This article develops a triadic co-evolutionary framework-the ITP model-that integrates institutional theory, technological evolution theory, and platform ecosystem theory to address this question. The study is positioned as a theory-building, qualitatively oriented single-case analysis supported by secondary documentary evidence and extended through structured cross-national comparison; it does not report primary empirical data. Drawing on China's medical esthetics social commerce sector as a "theory-laden" extreme case-in which multi-agency public health and consumer-protection regulatory pressure, deep generative-AI (AIGC) penetration, and platforms occupying dual commercial-regulatory roles are simultaneously present-we trace the mechanisms through which the three elements interact via a "constraint-enablement-transmission" channel across three co-evolutionary phases, with explicit attention to the public-health implications of governance dynamics. Cross-national comparative evidence from Republic of Korea and the European Union is incorporated to assess the framework's conditional generalizability for health-systems governance. The analysis identifies three structurally embedded tensions that the co-evolutionary process appears to generate: a temporal disjuncture between regulatory rigidity and technological elasticity that may compromise public-health responsiveness; a structural contradiction between platform growth imperatives and public-health compliance mandates, expressed as legitimacy deficits; and a compliance-cost escalation dynamic that is consistent with a self-reinforcing feedback loop of concentrated enforcement and market fragmentation, with downstream consequences for the safety, quality, and equitable accessibility of health-related services. We translate these mechanisms into explicit public-health propositions concerning patient safety, health equity, quality of care, health misinformation, and health-system resilience, and we situate the framework against the rapidly expanding 2024-2026 literatures on trustworthy AI, AI governance, algorithmic accountability, and digital-health governance. The ITP framework advances the public-health governance literature by suggesting that these tensions are emergent properties of triadic co-evolutionary interaction-not reducible to any single element's excess-and by specifying the boundary conditions under which the framework may generalize to other public-health-relevant regulated service industries, including telemedicine, online pharmacy, digital mental health, and platform-based care delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.